Top Markets
Coin of the day
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rang in aandelen #33711
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Aandeelprijs
$0.26800822
Marktkapitalisatie
$7.89M
Verandering (1 dag)
5.56%
Verandering (1 jaar)
11.35%
Land
AU
Handel Cambium Bio Limited (CMB)

Categorie

Dividendrendementgeschiedenis voor Cambium Bio Limited (CMB)
Het dividendrendement (TTM) van Cambium Bio Limited (aandelsymbool: CMB) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Cambium Bio Limited (CMB) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten